Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of KRP-209 in Patients with Subjective Tinnitus
jRCT2080221608Phase 2
- Sponsor
- Kyorin Pharmaceutical
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of neramexane in tinnitus, sponsored by Kyorin Pharmaceutical.
02
Drugs
neramexane
03
Conditions
tinnitus
Beyond the preview
Go deeper on jRCT2080221608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221608.